πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 54 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10383827

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Aug 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10328159

Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10098847

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10076545

Pharmaceutically compatible method for purifying intact bacterial minicells

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9987377

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact mi

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9878043

Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mamm

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9867785

Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9850323

High concentration chitosan-nucleic acid polyplex compositions

ENGENE, INC. Β· Granted Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9844598

Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9730897

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact min

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9731011

Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and int

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9623112

Dually derivatized chitosan nanoparticles and methods of making and using the same

ENGENE, INC. Β· Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9404088

Chitosan-based non-viral methods for transfecting gut cells in vivo

ENGENE, INC. Β· Granted Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9242007

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact min

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9169495

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact mi

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9066982

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8956864

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid f

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8846102

Non-viral compositions and methods for transfecting gut cells in vivo

ENGENE, INC. Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8772013

Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735566

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid f

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8722646

High concentration chitosan-nucleic acid polyplex compositions

ENGENE, INC. Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8691963

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact min

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8669101

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid f

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Mar 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8591862

Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mamm

EnGeneIC Molecular Delivery Pty Ltd Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted